GlyRS-IN-1 is primarily utilized in research focused on inhibiting glycyl-tRNA synthetase (GlyRS), an enzyme critical for protein synthesis. By targeting GlyRS, this compound is studied for its potential to disrupt bacterial protein production, making it a candidate for developing novel antibiotics, particularly against drug-resistant bacterial strains. Additionally, GlyRS-IN-1 is explored in understanding the role of GlyRS in cellular processes and its implications in diseases where protein synthesis is dysregulated. Its application extends to biochemical studies aimed at elucidating enzyme mechanisms and identifying new therapeutic targets.